Patient Guide: A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 120 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05456191
Status: ACTIVE_NOT_RECRUITING
Condition: Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Phase: PHASE3

Find a Study Location Near You

This study is available at 120 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Denver, Colorado
  • Peoria, Illinois
  • Saint Paul, Minnesota
  • • And 117 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily